share_log

罗欣药业(002793.SZ):拟向控股子公司北京健康增资

Luoxin Pharmaceuticals Group Stock (002793.SZ): Plans to increase capital for its controlling subsidiary BJ HEALTH.

Gelonghui Finance ·  Dec 24, 2024 03:41

On December 24, Gelonghui reported that Luoxin Pharmaceuticals Group Stock (002793.SZ) announced that its controlling subsidiary, BJ HEALTH Technology Development (Beijing) Co., Ltd. (referred to as "BJ HEALTH"), currently has a registered capital of RMB 233.6 million and plans to increase its registered capital by RMB 120 million. The company intends to subscribe to the aforementioned increase in registered capital of BJ HEALTH at the price of RMB 120 million using its own funds. After the completion of this capital increase, the registered capital of BJ HEALTH will change to RMB 353.6 million. Regarding this capital increase, another existing Shareholder of BJ HEALTH, Chengdu De Yixin Huaguang Private Equity Partnership (Limited Partnership) (hereinafter referred to as "Chengdu De Yixin"), has agreed in writing as a related party to waive its priority subscription right to make contributions proportionate to its existing capital contribution. After the completion of this capital increase, the company's shareholding percentage in BJ HEALTH will rise from 71.16% to 80.95%, maintaining its position as the controlling Shareholder and continuing to include it within the scope of consolidated financial statements, which have not changed.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment